Please wait for a moment.
S
HANALL BIOPHARMA
[Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)]
Toc
All
선택
Search
Prev
Next
Main Documents
Select
2024.10.31 Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)
Attachment Documents
Select
+Select Documents+
-Main Documents-
2024.10.31 Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)
Download
Print
Close
Index
☞ This disclosure is under the jurisdiction of [Korea Exchange’s Securities Market Headquarters].